David Williams to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications David Williams has written about Xenograft Model Antitumor Assays.
Connection Strength
0.114
-
Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy. Redox Biol. 2026 03; 90:103980.
Score: 0.059
-
Pleiotropic anti-cancer activities of novel non-covalent thioredoxin reductase inhibitors against triple negative breast cancer. Free Radic Biol Med. 2025 02 01; 227:201-209.
Score: 0.055